Slippers to Reduce Transfer From Floors to Surfaces

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

34 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-08-01

Study Completion Date

2021-04-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this study is to determine if wearing slippers will reduce transfer of bacteriophage MS2 from hospital room floors to surfaces in the room and hands of patients. Subjects are randomized to wear slippers versus standard care and cultures are collected at 24 and 48 hours to assess transfer of bacteriophage MS2 from the floor to high-touch surfaces, personal items, bedding, socks or feet, and hands of patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers

NCT01350479

Methicillin-Resistant Staphylococcus Aureus

COMPLETED

Preventing the Spread of Infection in Nursing Homes

NCT03319368

Staphylococcus Aureus

COMPLETED NA

Building an Optimal Hand Hygiene Bundle

NCT02223455

Hand Hygiene Health Care Associated Infection Compliance

COMPLETED NA

Clean Hands Accessible and Manageable for Patients (CHAMPs)

NCT05866393

Pathogen Transmission Patient Participation Aging

RECRUITING NA

Bacterial Contamination of Healthcare Worker Uniforms

NCT01537835

Bacterial Contamination of Healthcare Worker Uniforms

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The goal of this study is to determine if wearing slippers will reduce transfer of bacteriophage MS2 from hospital room floors to surfaces in the room and hands of patients. Hospitalized patients are enrolled and randomized to wear slippers any time they are out of bed versus standard care. Bacteriophage MS2 is inoculated onto a site on the floor between the patient bed and the bathroom. Cultures are collected at 24 and 48 hours to assess transfer of bacteriophage MS2 from the floor to high-touch surfaces (bed rail, bedside table, telephone, call button), personal items, bedding, socks or feet, and hands of patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Transmission, Other/Miscellaneous

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized trial

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Lab personnel processing cultures blinded to the study group

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Slippers

Patients wear slippers any time they are out of bed with a goal of avoiding any contact between socks/feet and the floor

Group Type EXPERIMENTAL

Slippers

Intervention Type BEHAVIORAL

Patients in the intervention group wear slippers when out of bed

Control

Patients receive standard care with no intervention

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Slippers

Patients in the intervention group wear slippers when out of bed

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients of 18 years of age or older
* Ambulatory
* Able to demonstrate an understanding of study procedures

Exclusion Criteria

* Unable or unwilling to fulfill study requirements.
* Expected length of stay less than 48 hours
* Any patient deemed not suitable for study participation at the discretion of the study investigator

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No